Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America - PubMed (original) (raw)

Practice Guideline

. 2019 Oct 1;200(7):e45-e67.

doi: 10.1164/rccm.201908-1581ST.

Grant W Waterer, Ann C Long, Antonio Anzueto, Jan Brozek, Kristina Crothers, Laura A Cooley, Nathan C Dean, Michael J Fine, Scott A Flanders, Marie R Griffin, Mark L Metersky, Daniel M Musher, Marcos I Restrepo, Cynthia G Whitney

• PMID: 31573350
• PMCID: PMC6812437
• DOI: 10.1164/rccm.201908-1581ST

Practice Guideline

Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America

Joshua P Metlay et al. Am J Respir Crit Care Med. 2019.

Abstract

Background: This document provides evidence-based clinical practice guidelines on the management of adult patients with community-acquired pneumonia.Methods: A multidisciplinary panel conducted pragmatic systematic reviews of the relevant research and applied Grading of Recommendations, Assessment, Development, and Evaluation methodology for clinical recommendations.Results: The panel addressed 16 specific areas for recommendations spanning questions of diagnostic testing, determination of site of care, selection of initial empiric antibiotic therapy, and subsequent management decisions. Although some recommendations remain unchanged from the 2007 guideline, the availability of results from new therapeutic trials and epidemiological investigations led to revised recommendations for empiric treatment strategies and additional management decisions.Conclusions: The panel formulated and provided the rationale for recommendations on selected diagnostic and treatment strategies for adult patients with community-acquired pneumonia.

Keywords: community-acquired pneumonia; pneumonia; patient management.

PubMed Disclaimer

Comment in

• Summary for Clinicians: Clinical Practice Guideline for the Diagnosis and Treatment of Community-acquired Pneumonia.
  Jones BE, Herman DD, Dela Cruz CS, Waterer GW, Metlay JP, Ruminjo JK, Thomson CC. Jones BE, et al. Ann Am Thorac Soc. 2020 Feb;17(2):133-138. doi: 10.1513/AnnalsATS.201909-704CME. Ann Am Thorac Soc. 2020. PMID: 31770496 No abstract available.
• Multidisciplinary Authorship in Clinical Practice Guidelines: An Opportunity for Inclusion.
  Chahine EB. Chahine EB. Am J Respir Crit Care Med. 2020 Mar 15;201(6):743-744. doi: 10.1164/rccm.201910-1908LE. Am J Respir Crit Care Med. 2020. PMID: 31800259 Free PMC article. No abstract available.
• Viewing the Community-acquired Pneumonia Guidelines through an Antibiotic Stewardship Lens.
  Fabre V, Spivak ES, Keller SC. Fabre V, et al. Am J Respir Crit Care Med. 2020 Mar 15;201(6):745-746. doi: 10.1164/rccm.201910-2026LE. Am J Respir Crit Care Med. 2020. PMID: 31800265 Free PMC article. No abstract available.
• Reply to Chahine, to Schuetz, and to Fabre et al.
  Metlay JP, Waterer GW. Metlay JP, et al. Am J Respir Crit Care Med. 2020 Mar 15;201(6):746-747. doi: 10.1164/rccm.201910-2000LE. Am J Respir Crit Care Med. 2020. PMID: 31800266 Free PMC article. No abstract available.
• 2019 Community-acquired Pneumonia Treatment Guidelines: There Is a Need for a Change toward More Parsimonious Antibiotic Use.
  Huttner B, Cappello B, Cooke G, Gandra S, Harbarth S, Imi M, Loeb M, Mendelson M, Moja L, Pulcini C, Sharland M, Tacconnelli E, Zeng M, Magrini N. Huttner B, et al. Am J Respir Crit Care Med. 2020 May 15;201(10):1315-1316. doi: 10.1164/rccm.201911-2226LE. Am J Respir Crit Care Med. 2020. PMID: 32069065 Free PMC article. No abstract available.
• Reply to Huttner et al.: 2019 Community-acquired Pneumonia Treatment Guidelines: There Is a Need for a Change toward More Parsimonious Antibiotic Use.
  Metlay JP, Waterer GW. Metlay JP, et al. Am J Respir Crit Care Med. 2020 May 15;201(10):1316-1317. doi: 10.1164/rccm.202001-0164LE. Am J Respir Crit Care Med. 2020. PMID: 32069069 Free PMC article. No abstract available.
• Antibiotic-resistant bacteria: COVID-19 hasn't made the challenge go away.
  Waterer G, Pickens CI, Wunderink R. Waterer G, et al. Respirology. 2021 Nov;26(11):1024-1026. doi: 10.1111/resp.14166. Epub 2021 Oct 1. Respirology. 2021. PMID: 34596927 Free PMC article. No abstract available.

Similar articles

• The hospitalist perspective on treatment of community-acquired bacterial pneumonia.
  Amin AN, Cerceo EA, Deitelzweig SB, Pile JC, Rosenberg DJ, Sherman BM. Amin AN, et al. Postgrad Med. 2014 Mar;126(2):18-29. doi: 10.3810/pgm.2014.03.2737. Postgrad Med. 2014. PMID: 24685965 Review.
• Diagnosis and management of community-acquired pneumonia in adults.
  Watkins RR, Lemonovich TL. Watkins RR, et al. Am Fam Physician. 2011 Jun 1;83(11):1299-306. Am Fam Physician. 2011. PMID: 21661712
• [Comparative analysis of guidelines for the treatment of community-acquired pneumonias].
  Rodríguez de Castro F. Rodríguez de Castro F. Arch Bronconeumol. 1999 Jun;35(6):253-6. Arch Bronconeumol. 1999. PMID: 10410203 Spanish. No abstract available.
• [Management of community-acquired pneumonia in the physician's office].
  Lode HM, Erbes R, Linnhoff A. Lode HM, et al. MMW Fortschr Med. 2006 Jan 12;148(1-2):32-5. doi: 10.1007/BF03364510. MMW Fortschr Med. 2006. PMID: 16610411 German.
• Emergency management of community-acquired bacterial pneumonia: what is new since the 2007 Infectious Diseases Society of America/American Thoracic Society guidelines.
  Moran GJ, Rothman RE, Volturo GA. Moran GJ, et al. Am J Emerg Med. 2013 Mar;31(3):602-12. doi: 10.1016/j.ajem.2012.12.002. Epub 2013 Feb 4. Am J Emerg Med. 2013. PMID: 23380120

Cited by

• Distinction of clinical features and microbiological methods between Chlamydia psittaci and Legionella pneumophila pneumonia confirmed by metagenomic next-generation sequencing.
  Shi L, Zhang D, Yang Q, Yang J, Zhu H. Shi L, et al. Ann Med. 2024 Dec;56(1):2428433. doi: 10.1080/07853890.2024.2428433. Epub 2024 Nov 14. Ann Med. 2024. PMID: 39541434 Free PMC article.
• Comparing the Efficacy of Empirical Anti-Infective Therapy and Follow-Up Observation for Newly Diagnosed Pulmonary Ground-Glass Nodules With Suspected Inflammatory Etiology: A Multicenter Prospective Observational Study Protocol.
  Feng W, He T, Zhang Y, Mu Y, Pu Y, Liu Y, Ouyang Z, Song H, Zhong Y, Lu H, Zhou Y, Zou P, Yang G, Tian H, Jin J, Liang G, Yang L, Zhang L, Liu Y, Dai W, Qing H, Zhang J, Shi Q, Li Q, Yang D, Zhang R, Wei X. Feng W, et al. Health Sci Rep. 2024 Nov 13;7(11):e70201. doi: 10.1002/hsr2.70201. eCollection 2024 Nov. Health Sci Rep. 2024. PMID: 39540029 Free PMC article.
• The Brief Case: A fatal case of Legionella pneumophila in an elderly patient.
  Sulaiman A, Gisriel E, Carroll KC. Sulaiman A, et al. J Clin Microbiol. 2024 Nov 13;62(11):e0086324. doi: 10.1128/jcm.00863-24. Epub 2024 Nov 13. J Clin Microbiol. 2024. PMID: 39535209 Review. No abstract available.
• Community-Acquired Pneumonia in the Immunocompromised Patients: An Observational Study from a Single Center, TURKEY.
  Yılmaz E, Benli A, Başaran S, Şimşek-Yavuz S, Cagatay A, Oncul MO, Özsüt H, Eraksoy H. Yılmaz E, et al. Infect Drug Resist. 2024 Nov 6;17:4875-4885. doi: 10.2147/IDR.S480520. eCollection 2024. Infect Drug Resist. 2024. PMID: 39524981 Free PMC article.
• Agreement and comparative accuracy of instability criteria at discharge for predicting adverse events in patients with community-acquired pneumonia.
  Danjou A, Bouisse M, Boussat B, Blaise S, Gaillat J, Francois P, Courtois X, Sellier E, Toffart AC, Schwebel C, Halm EA, Labarere J. Danjou A, et al. BMJ Open Respir Res. 2024 Nov 7;11(1):e002289. doi: 10.1136/bmjresp-2024-002289. BMJ Open Respir Res. 2024. PMID: 39510793 Free PMC article.

References

1. 1. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44:S27–S72. - PMC - PubMed
2. 1. Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64:395–400. - PubMed
3. 1. Metlay JP, Kapoor WN, Fine MJ. Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination. JAMA. 1997;278:1440–1445. - PubMed
4. 1. Sato T, Aoshima M, Ohmagari N, Tada H, Chohnabayashi N. Usefulness of sputum Gram staining in community-acquired pneumonia [in Japanese] Nihon Kokyuki Gakkai Zasshi. 2002;40:558–563. - PubMed
5. 1. Shariatzadeh MR, Marrie TJ. Does sputum culture affect the management and/or outcome of community-acquired pneumonia? East Mediterr Health J. 2009;15:792–799. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central

• Other Literature Sources

  • H1 Connect
  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information